UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 141

Sortiert nach

A quick, simple and unbiased method to quantify C2C12 myogenic differentiation

Muscle & nerve, 2011-09, Vol.44 (3), p.366-370

2011

Link zum Volltext

Verfügbarkeit prüfen

The ‘known-knowns', and ‘known-unknowns' of extracellular Nm23-H1/NDPK proteins

Laboratory investigation, 2018-05, Vol.98 (5), p.602-608

2018

Link zum Volltext

Verfügbarkeit prüfen

Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies

Blood cancer journal (New York), 2022-10, Vol.12 (10), p.142-142, Article 142

2022

Link zum Volltext

Verfügbarkeit prüfen

Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids

Cancer research (Chicago, Ill.), 2015-06, Vol.75 (12), p.2530-2540

2015

Link zum Volltext

Verfügbarkeit prüfen

Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing

British journal of cancer, 2022-02, Vol.126 (2), p.275-286

2022

Link zum Volltext

Verfügbarkeit prüfen

Africa's Media Image in the 21st Century: From the "Heart of Darkness" to "Africa Rising"

1, 2017

Link zum Volltext

Verfügbarkeit prüfen

Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia

PloS one, 2009-12, Vol.4 (12), p.e8147-e8147

2009

Link zum Volltext

Verfügbarkeit prüfen

Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

Molecular cancer, 2009-12, Vol.8 (1), p.121-121, Article 121

2009

Link zum Volltext

Verfügbarkeit prüfen

Active multiple myeloma suppresses and typically eliminates coexisting MGUS

British journal of cancer, 2017-09, Vol.117 (6), p.835-839

2017

Link zum Volltext

Verfügbarkeit prüfen

AKR1C Isoforms Represent a Novel Cellular Target for Jasmonates alongside Their Mitochondrial-Mediated Effects

Cancer research (Chicago, Ill.), 2009-06, Vol.69 (11), p.4769-4775

2009

Link zum Volltext

Verfügbarkeit prüfen

Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance

Haematologica (Roma), 2010-11, Vol.95 (11), p.1889-1896

2010

Link zum Volltext

Verfügbarkeit prüfen

The Role of Eif6 in Skeletal Muscle Homeostasis Revealed by Endurance Training Co-expression Networks

Cell reports (Cambridge), 2017-11, Vol.21 (6), p.1507-1520

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches

Leukemia & lymphoma, 2012-04, Vol.53 (4), p.537-549

2012

Link zum Volltext

Verfügbarkeit prüfen

Prostaglandin D2 inhibits C2C12 myogenesis

Molecular and cellular endocrinology, 2010-05, Vol.319 (1-2), p.71-78

2010

Link zum Volltext

Verfügbarkeit prüfen

Prostaglandins in muscle regeneration

Journal of muscle research and cell motility, 2008-12, Vol.29 (6-8), p.163-167

2008

Link zum Volltext

Verfügbarkeit prüfen

Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers

Contemporary clinical trials communications, 2019-06, Vol.14, p.100361-100361, Article 100361

2019

Link zum Volltext

Verfügbarkeit prüfen

Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)

British journal of haematology, 2010-04, Vol.149 (1), p.65-69

2010

Link zum Volltext

Verfügbarkeit prüfen

Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study

The Lancet. Haematology, 2017-12, Vol.4 (12), p.e584-e594

2017

Link zum Volltext

Verfügbarkeit prüfen

Elevated FOSB‐expression; a potential marker of valproate sensitivity in AML

British journal of haematology, 2009-02, Vol.144 (3), p.332-341

2009

Link zum Volltext

Verfügbarkeit prüfen

Correction: Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

Molecular cancer, 2010-01, Vol.9 (1), p.21-21

2010

Link zum Volltext

Verfügbarkeit prüfen

Where now in elderly AML?

British journal of haematology, 2009-05, Vol.145 (3), p.333-333

Bunce, Chris

2009

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

Molecular cancer, 2010-01, Vol.9 (1), Article 21

2010

Link zum Volltext

Verfügbarkeit prüfen

Prostaglandin D 2 inhibits C2C12 myogenesis

Molecular and cellular endocrinology, 2010-05, Vol.319 (1), p.71-78

2010

Link zum Volltext

Verfügbarkeit prüfen

Epilepsy doses of valproate combined with the anti-helminthic, niclosamide, synergistically kill myeloma cells: A potent new anti-myeloma drug combination

Experimental hematology, 2014-08, Vol.42 (8), p.S26-S26

2014

Link zum Volltext

Verfügbarkeit prüfen

The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis

Mutation research, 2009-03, Vol.662 (1), p.67-74

2009

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(132)

Publikationsform

Sprache

Englisch
(141)
Japanisch
(11)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

A quick, simple and unbiased method to quantify C2C12 myogenic differentiation

The ‘known-knowns', and ‘known-unknowns' of extracellular Nm23-H1/NDPK proteins

Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies

Drug Redeployment to Kill Leukemia and Lymphoma Cells by Disrupting SCD1-Mediated Synthesis of Monounsaturated Fatty Acids

Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing

Africa's Media Image in the 21st Century: From the "Heart of Darkness" to "Africa Rising"

Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia

Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

Active multiple myeloma suppresses and typically eliminates coexisting MGUS

AKR1C Isoforms Represent a Novel Cellular Target for Jasmonates alongside Their Mitochondrial-Mediated Effects

Lycorine sensitizes CD40 ligand-protected chronic lymphocytic leukemia cells to bezafibrate- and medroxyprogesterone acetate-induced apoptosis but dasatanib does not overcome reported CD40-mediated drug resistance

The Role of Eif6 in Skeletal Muscle Homeostasis Revealed by Endurance Training Co-expression Networks

Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches

Prostaglandin D2 inhibits C2C12 myogenesis

Prostaglandins in muscle regeneration

Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers

Combined bezafibrate and medroxyprogesterone acetate have efficacy without haematological toxicity in elderly and relapsed acute myeloid leukaemia (AML)

Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study

Elevated FOSB‐expression; a potential marker of valproate sensitivity in AML

Correction: Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

Where now in elderly AML?

Erratum to: Lack of functional and expression homology between human and mouse aldo-keto reductase 1C enzymes: implications for modelling human cancers

Prostaglandin D 2 inhibits C2C12 myogenesis

Epilepsy doses of valproate combined with the anti-helminthic, niclosamide, synergistically kill myeloma cells: A potent new anti-myeloma drug combination

The aldo-keto reductase AKR1C3 contributes to 7,12-dimethylbenz(a)anthracene-3,4-dihydrodiol mediated oxidative DNA damage in myeloid cells: Implications for leukemogenesis

Suchergebnisse filtern